VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 242,428,011
- Share change
- -1,716,557
- Total reported value
- $70,341,346,452
- Put/Call ratio
- 106%
- Price per share
- $290.31
- Number of holders
- 949
- Value change
- -$453,115,099
- Number of buys
- 558
- Number of sells
- 326
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
8.9%
|
22,656,588
|
$5,391,136,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
8.8%
|
22,326,048
|
$5,312,483,000 | — | 31 Mar 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.5%
|
21,623,906
|
$5,145,409,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
20,608,939
|
$4,903,897,000 | — | 31 Mar 2020 | |
| Capital World Investors |
13F
|
Company |
4.9%
|
12,579,718
|
$2,993,340,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
4.5%
|
11,449,243
|
$2,724,347,000 | — | 31 Mar 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3%
|
7,611,768
|
$1,811,221,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.7%
|
6,859,682
|
$1,632,261,000 | — | 31 Mar 2020 | |
| Capital International Investors |
13F
|
Company |
2.6%
|
6,542,598
|
$1,556,807,000 | — | 31 Mar 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
2.4%
|
6,193,851
|
$1,473,827,000 | — | 31 Mar 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.7%
|
4,361,755
|
$1,037,880,000 | — | 31 Mar 2020 | |
| Clearbridge Investments, LLC |
13F
|
Company |
1.5%
|
3,841,094
|
$913,988,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
3,809,371
|
$904,584,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
2,859,959
|
$680,528,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
1.1%
|
2,751,663
|
$654,758,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
1%
|
2,537,913
|
$603,896,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.98%
|
2,492,624
|
$593,120,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.86%
|
2,194,775
|
$522,247,000 | — | 31 Mar 2020 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.85%
|
2,172,894
|
$517,046,000 | — | 31 Mar 2020 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
0.81%
|
2,063,377
|
$490,981,000 | — | 31 Mar 2020 | |
| HARDING LOEVNER LP |
13F
|
Company |
0.8%
|
2,047,274
|
$487,149,000 | — | 31 Mar 2020 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.73%
|
1,871,635
|
$445,355,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.69%
|
1,752,980
|
$417,120,000 | — | 31 Mar 2020 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.65%
|
1,658,360
|
$394,606,000 | — | 31 Mar 2020 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
1,640,577
|
$390,375,000 | — | 31 Mar 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.62%
|
1,584,802
|
$376,926,000 | — | 31 Mar 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.55%
|
1,403,326
|
$333,921,423 | — | 31 Mar 2020 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.54%
|
1,369,311
|
$325,828,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
1,352,347
|
$321,791,000 | — | 31 Mar 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.53%
|
1,339,784
|
$318,801,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.51%
|
1,301,741
|
$309,749,000 | — | 31 Mar 2020 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.51%
|
1,298,209
|
$308,909,000 | — | 31 Mar 2020 | |
| Bellevue Group AG |
13F
|
Company |
0.5%
|
1,273,089
|
$302,932,000 | — | 31 Mar 2020 | |
| Capital Research Global Investors |
13F
|
Company |
0.49%
|
1,250,664
|
$297,595,000 | — | 31 Mar 2020 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.48%
|
1,226,786
|
$291,914,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.46%
|
1,165,514
|
$277,335,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.43%
|
1,102,012
|
$262,224,000 | — | 31 Mar 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.43%
|
1,099,241
|
$261,565,000 | — | 31 Mar 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.43%
|
1,091,795
|
$259,793,000 | — | 31 Mar 2020 | |
| Swiss National Bank |
13F
|
Company |
0.41%
|
1,036,075
|
$246,534,000 | — | 31 Mar 2020 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.4%
|
1,025,420
|
$243,998,000 | — | 31 Mar 2020 | |
| 1832 Asset Management L.P. |
13F
|
Company |
0.4%
|
1,009,900
|
$233,245,000 | — | 31 Mar 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.37%
|
951,159
|
$226,328,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.37%
|
939,311
|
$223,510,000 | — | 31 Mar 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.36%
|
926,187
|
$220,386,000 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.36%
|
910,952
|
$216,761,000 | — | 31 Mar 2020 | |
| EATON VANCE MANAGEMENT |
13F
|
Company |
0.35%
|
879,562
|
$209,293,000 | — | 31 Mar 2020 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.32%
|
808,769
|
$192,447,000 | — | 31 Mar 2020 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.31%
|
799,448
|
$190,230,000 | — | 31 Mar 2020 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.3%
|
767,571
|
$182,644,000 | — | 31 Mar 2020 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2020
As of 30 Jun 2020,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
949 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
242,428,011 shares.
The largest 10 holders included
BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, FMR LLC, Capital World Investors, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, ALLIANCEBERNSTEIN L.P., RENAISSANCE TECHNOLOGIES LLC, and Capital International Investors.
This page lists
950
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
842
Q2 2020 holders
949
Holder diff
107
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.